195 related articles for article (PubMed ID: 31605172)
21. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
22. Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas.
Durante C; Attard M; Torlontano M; Ronga G; Monzani F; Costante G; Ferdeghini M; Tumino S; Meringolo D; Bruno R; De Toma G; Crocetti U; Montesano T; Dardano A; Lamartina L; Maniglia A; Giacomelli L; Filetti S;
J Clin Endocrinol Metab; 2010 Nov; 95(11):4882-8. PubMed ID: 20660054
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
24. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
25. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
26. Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes.
Price AK; Randle RW; Schneider DF; Sippel RS; Pitt SC
J Surg Res; 2017 Oct; 218():237-245. PubMed ID: 28985856
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
28. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
29. Incidental and nonincidental papillary thyroid microcarcinoma.
Lin JD; Kuo SF; Chao TC; Hsueh C
Ann Surg Oncol; 2008 Aug; 15(8):2287-92. PubMed ID: 18483830
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
[No Abstract] [Full Text] [Related]
31. Total thyroidectomy: safe and adequate treatment for papillary microcarcinoma of the thyroid gland.
Uhliarova B; Hajtman A
B-ENT; 2016 Aug; 12(2):119-124. PubMed ID: 29553616
[TBL] [Abstract][Full Text] [Related]
32. Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma.
Untch BR; Palmer FL; Ganly I; Patel SG; Michael Tuttle R; Shah JP; Shaha AA
Ann Surg Oncol; 2014 Apr; 21(4):1374-8. PubMed ID: 24366419
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma.
Jeon MJ; Kim WG; Kwon H; Kim M; Park S; Oh HS; Han M; Sung TY; Chung KW; Hong SJ; Kim TY; Shong YK; Kim WB
Eur J Endocrinol; 2017 Jul; 177(1):25-31. PubMed ID: 28432268
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinoma.
Yi D; Song P; Huang T; Tang X; Sang J
Oncotarget; 2017 Jan; 8(4):7148-7156. PubMed ID: 27756889
[TBL] [Abstract][Full Text] [Related]
35. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
36. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
37. The overtreatment of papillary thyroid microcarcinoma in the community.
Abraham PJ; Wu C; Wang R; Herring B; Zmijewski P; Gillis A; Fazendin J; Lindeman B; Chen H
Am J Surg; 2024 Jul; 233():132-135. PubMed ID: 38462410
[TBL] [Abstract][Full Text] [Related]
38. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
Ito Y; Miyauchi A
Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
[No Abstract] [Full Text] [Related]
39. Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease.
Slijepcevic N; Zivaljevic V; Marinkovic J; Sipetic S; Diklic A; Paunovic I
BMC Cancer; 2015 Apr; 15():330. PubMed ID: 25925164
[TBL] [Abstract][Full Text] [Related]
40. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
